These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34627629)

  • 1. Antihypertensive drugs demonstrate varying levels of hip fracture risk: A systematic review and meta-analysis.
    Langerhuizen DWG; Verweij LPE; van der Wouden JC; Kerkhoffs GMMJ; Janssen SJ
    Injury; 2022 Mar; 53(3):1098-1107. PubMed ID: 34627629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.
    Ruths S; Bakken MS; Ranhoff AH; Hunskaar S; Engesæter LB; Engeland A
    BMC Geriatr; 2015 Dec; 15():153. PubMed ID: 26626043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies.
    Wiens M; Etminan M; Gill SS; Takkouche B
    J Intern Med; 2006 Oct; 260(4):350-62. PubMed ID: 16961672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.
    Bokrantz T; Schiöler L; Boström KB; Kahan T; Mellström D; Ljungman C; Hjerpe P; Hasselström J; Manhem K
    J Hypertens; 2020 Jan; 38(1):167-175. PubMed ID: 31568060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
    Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
    BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
    Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
    Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive drugs and the risk of fall injuries: a systematic review and meta-analysis.
    Zang G
    J Int Med Res; 2013 Oct; 41(5):1408-17. PubMed ID: 24051019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
    Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: impact of drug class on adherence to antihypertensives.
    Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
    Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line drugs for hypertension.
    Wright JM; Musini VM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD001841. PubMed ID: 19588327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Seleme VB; Marques GL; Mendes AEM; Rotta I; Pereira M; Júnior EL; da Cunha CLP
    Am J Cardiovasc Drugs; 2021 Mar; 21(2):165-180. PubMed ID: 32710438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis.
    den Brok MGHE; van Dalen JW; Abdulrahman H; Larson EB; van Middelaar T; van Gool WA; van Charante EPM; Richard E
    J Am Med Dir Assoc; 2021 Jul; 22(7):1386-1395.e15. PubMed ID: 33460618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.